Results 11 to 20 of about 4,026 (142)
A Rare Side Effect of Entecavir: Hepatomegaly and Steatosis
Viral Hepatitis Journal, 2017 Hepatomegaly and steatosis are rare but potentially fatal side-effects of nucleoside analogues. Here, we present the case of development of hepatomegaly and steatosis in a 53-year-old male who had been treated with entecavir for five years. There were no
Tayibe BAL +2 more
doaj +2 more sources
[Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience] [PDF]
Clinical Management Issues, 2015 BACKGROUND AND AIM: The current treatment of chronic hepatitis B infection (CHBV) has achieved several step-ups thanks to the introduction of the new-generation nucleos(t)ide analogs.
Fabio Tarsetti +4 more
doaj +2 more sources
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
Gut and Liver, 2016 Background/AimsAntiviral therapy is a key component in the management of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients. However, whether the potent drug entecavir is more effective than a less potent drug, such as lamivudine, in
Jung Hee Kim +9 more
doaj +2 more sources
Clinical utility of entecavir for chronic hepatitis B in Chinese patients
Drug Design, Development and Therapy, 2013 Jiyao WangZhongshan Hospital, Fudan University, Shanghai, Key Laboratory of Medical Molecular Virology of MOE/MOH, Shanghai, People’s Republic of ChinaAbstract: The People’s Republic of China has one of the highest rates of hepatitis B virus (
Wang JY
doaj +1 more source
Viruses, 2021 As current interventions for chronic hepatitis B (CHB) rarely induce cure, more effective drugs are needed. Short-term treatment of woodchucks with the novel immunomodulator AIC649, a parapoxvirus-based stimulator of toll-like receptor 9 dependent and ...
Kyle E. Korolowicz +8 more
doaj +2 more sources
Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B
Annals of Hepatology, 2016 Background and aims. CD4+ T cells play an important role in response to hepatitis B virus (HBV) infection. We investigated the change in CD4+ T-cell subpopulations and viral load in patients with chronic HBV infection who were treated with entecavir ...
Tian Zhan-Fei +4 more
doaj +2 more sources
THE EXPERIENCE OF ENTECAVIR USE IN PATIENTS WITH HEPATITIS B VIRAL INFECTION ON AN OUTPATIENT BASIS
Alʹmanah Kliničeskoj Mediciny, 2016 Aim: To evaluate retrospectively the efficacy and safety of entecavir in treatment-naïve patients with hepatitis B viral infection.Materials and methods: Based on patient medical documentation, we analyzed the results of clinical, virologic and ...
L. I. Mel'nikova, L. Yu. Il'chenko
doaj +2 more sources
Experience of entecavir therapy in chronic hepatitis B [PDF]
Журнал инфектологии, 2014 Entecavir is a potent and selective guanosine analogue that has demonstrated a significant antiviral efficacy against hepatitis B virus. The purpose of this article was to characterize the response to entecavir and it portability.
E. V. Esaulenko +4 more
doaj +2 more sources
Enfermedades Infecciosas y Microbiología Clínica, 2008 Chronic hepatitis B continues to be a serious problem worldwide. Because a high viral load is associated with greater progression to cirrhosis and hepatocarcinoma in these patients, new drugs that achieve rapid, potent and lasting suppression of viral replication must be sought.
José Luis, Calleja, Beatriz, Peñas
openaire +4 more sources
“Black box warning” rash with entecavir - case report
BMC Gastroenterology, 2020 Background Hepatitis B infection is a significant worldwide health issue, predispose to the development of liver cirrhosis and hepatocellular carcinoma.
Xiong Khee Cheong +3 more
doaj +1 more source